Breast Cancer, Male
What's New
Last Posted: Feb 03, 2023
- Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review.
Subarnarekha Chatterji et al. The Lancet. Oncology 2023 24(2) e74-e85 - Men With Breast Cancer Need More Treatment Options and Access to Genetic Counseling
FDA, June 2021 - Breast Cancer Among Men
T Ellington, CDC Blog, October 2020 - After a Breast Cancer Diagnosis, Men May Be More Likely to Die than Women
NCI, October 2, 2019 - Mathew Knowles reveals he is battling breast cancer: 'We need men to speak out'
H FitzPatrick et al, ABC Good Morning America, October 2, 2019 - Overall Mortality After Diagnosis of Breast Cancer in Men vs Women.
Wang Fei et al. JAMA oncology 2019 Sep - Men at High Risk for Breast Cancer May Benefit From Screening
R Nelson, Medscape, September 17, 2019 - Breast Cancer in Men.
Giordano Sharon H et al. The New England journal of medicine 2018 Jun 378(24) 2311-2320 - What happens when a man gets breast cancer
The Star, February 11, 2017 - Genomic profiling of male breast cancer
TK Burki, Lancet Oncology, March 2016
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 04, 2023
- Content source: